技术支持

技术支持

Systemic N-terminal fragments of adrenocorticotropin reduce inflammation- and stress-induced anhedonia in rats

  • 分类:文献库
  • 作者:
  • 来源:ScienceDirect
  • 发布时间:2022-01-26 13:27
  • 访问量:

Systemic N-terminal fragments of adrenocorticotropin reduce inflammation- and stress-induced anhedonia in rats

详情

Systemic N-terminal fragments of adrenocorticotropin reduce inflammation- and stress-induced anhedonia in rats

Highlights

  • Acute systemic pretreatment with ACTH(4-10) or α-MSH attenuates LPS-induced anhedonia.
  • Systemic treatment with ACTH(4-10) or α-MSH prevents chronic stress-induced anhedonia.
  • Treatment with ACTH(4-10) or α-MSH reduces chronic stress-induced body weight loss.
  • Delayed ACTH(4-10) treatment of stressed rats reduces anhedonia and body weight loss.
  • The corticotropic region of ACTH contains peptides with antidepressant-like effects.

Abstract

Emerging evidence implicates impaired self-regulation of the hypothalamic–pituitary–adrenal (HPA) axis and inflammation as important and closely related components of the pathophysiology of major depression. Antidepressants show anti-inflammatory effects and are suggested to enhance glucocorticoid feedback inhibition of the HPA axis. HPA axis activity is also negatively self-regulated by the adrenocorticotropic hormone (ACTH), a potent anti-inflammatory peptide activating five subtypes of melanocortin receptors (MCRs). There are indications that ACTH-mediated feedback can be activated by noncorticotropic N-terminal ACTH fragments such as a potent anti-inflammatory MC1/3/4/5R agonist α-melanocyte-stimulating hormone (α-MSH), corresponding to ACTH(1-13), and a MC3/5R agonist ACTH(4-10). We investigated whether intraperitoneal administration of rats with these peptides affects anhedonia, which is a core symptom of depression. Inflammation-related anhedonia was induced by a single intraperitoneal administration of a low dose (0.025 mg/kg) of lipopolysaccharide (LPS). Stress-related anhedonia was induced by the chronic unpredictable stress (CUS) procedure. The sucrose preference test was used to detect anhedonia. We found that ACTH(4-10) pretreatment decreased LPS-induced increase in serum corticosterone and tumor necrosis factor (TNF)-α, and a MC3/4R antagonist SHU9119 blocked this effect. Both α-MSH and ACTH(4-10) alleviated LPS-induced anhedonia. In the CUS model, these peptides reduced anhedonia and normalized body weight gain. The data indicate that systemic α-MSH and ACTH(4-10) produce an antidepressant-like effect on anhedonia induced by stress or inflammation, the stimuli that trigger the release of ACTH and α-MSH into the bloodstream. The results suggest a counterbalancing role of circulating melanocortins in depression and point to a new approach for antidepressant treatment.

相关文件

暂时没有内容信息显示
请先在网站后台添加数据记录。

底部联系方式信息(左)

发布时间:2022-01-27 11:34:07

400-687-1881

公司电话:010-87875910

公司邮箱:info@bio-life.cn

公司官网:www.acciusa.cn   www.bio-life.cn

公司地址:北京市大兴区中关村科技园区大兴生物医药产业基地

华佗路50号院18幢

这是描述信息

关注官方微信

这是描述信息

关注手机网站